Zheng Li
- Molecular Biology top 5%
- Endocrinology, Diabetes and Metabolism top 2%
- Surgery top 10%
- Epidemiology top 10%
- Pharmacology top 2%
- Topics
- Diabetes Treatment and Management (29 papers)Receptor Mechanisms and Signaling (25 papers)Peroxisome Proliferator-Activated Receptors (15 papers)
- Partner nations
- ChinaUnited StatesSouth Korea
In The Last Decade
Zheng Li
134 papers receiving 2.6k citations
Peers
Comparison fields: 5 of 130
- Molecular Biology 1.4k
- Endocrinology, Diabetes and Metabolism 601
- Surgery 471
- Epidemiology 371
- Pharmacology 254
Countries citing papers authored by Zheng Li
This map shows the geographic impact of Zheng Li's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Zheng Li with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Zheng Li more than expected).
Fields of papers citing papers by Zheng Li
This network shows the impact of papers produced by Zheng Li. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Zheng Li. The network helps show where Zheng Li may publish in the future.
Co-authorship network of co-authors of Zheng Li
This figure shows the co-authorship network connecting the top 25 collaborators of Zheng Li. A scholar is included among the top collaborators of Zheng Li based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Zheng Li. Zheng Li is excluded from the visualization to improve readability, since they are connected to all nodes in the network.
All Works
| # | Work | Indexed citations |
|---|---|---|
| 1 | 2 | |
| 2 | 1 | |
| 3 | 2 | |
| 4 | 6 | |
| 5 | 18 | |
| 6 | 75 | |
| 7 | 12 | |
| 8 | 79 | |
| 9 | 8 | |
| 10 | 135 | |
| 11 | 17 | |
| 12 | 25 | |
| 13 | 43 | |
| 14 | 22 | |
| 15 | 80 | |
| 16 | Simulated Weightlessness Affects the Serum Gastrin,Motilin,and In terstitial Cells of Cajal in Rat Gastric Antrum | 1 |
| 17 | 23 | |
| 18 | 6 | |
| 19 | Studies on quantitative determination methods of tacrolimus in the fermentation broth | 3 |
| 20 | Potentiation of the antinociceptive effect of endomorphin-1 by verapamil in the rat | 1 |
About Zheng Li
Zheng Li is a scholar working on Endocrinology, Diabetes and Metabolism, Pharmacology and Nephrology, having authored 138 papers that have together received 2.7k indexed citations. Recurring topics across this work include Diabetes Treatment and Management (29 papers), Receptor Mechanisms and Signaling (25 papers) and Peroxisome Proliferator-Activated Receptors (15 papers). The work is most often cited by research in Endocrinology, Diabetes and Metabolism (601 citations), Pharmacology (254 citations) and Molecular Biology (1.4k citations). Zheng Li has collaborated with scholars based in China, United States and South Korea. Frequent co-authors include Hai Qian, Wenlong Huang, Luyong Zhang, Haihua Feng, Bingyu Shen, Zongtao Zhou, Qiaoling Zhang, Xue Xu, Xuekun Wang and Ye Tian. Their work appears in journals such as Journal of Biological Chemistry, Angewandte Chemie International Edition and Diabetes.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.